Cultivating brand advantage for CDMOs

Tackling the perennial challenge of innovation in the pharmaceutical industry

picture of Joel Biswas, Coley Porter Bell

Breaking News

EMA completes pre-approval inspection at WuXi Biologics

The European Medicines Agency has examined cGMP facilities for the production of Trogarzo

Lonza allies with Emerald Health on synthetic cannabinoid therapy

The Swiss CDMO has signed a manufacturing agreement to produce the active ingredient of a cannabinoid therapy for ...

WuXi Biologics inks commercial agreement with Amicus

Chinese biotech company has become exclusive drug substance manufacturing partner and key commercial drug product ...

IIoT: shaping pharma’s future

Government regulation has presented new hurdles to the pharmaceutical and medical device industries within the last ...

EirGen Pharma expands R&D and contract manufacturing services

New R&D facility in Ireland increases EirGen’s high potency and containment product manufacturing

Central Pharma to expand contract packaging and supply chain services

The facility at IDA Advanced Technology Building in Tralee, Ireland will create 100 jobs

Making a difference in pharma contract manufacturing

With a plant near Basel, Switzerland, and a heritage of more than 40 years, contract service provider Legacy ...

Lonza reports CHF5.5 billion in sales in 2018

Full-year financials for the Swiss CDMO show 9% increase in organic sales

Lonza starts commercial supply of Portola’s second-gen coagulant

The FDA Prior Approval Supplement has been authorised and second-gen Andexxa will be produced on a large scale

Stability studies are ever changing: outsourcing as a viable option

After efficacy, stability is arguably a pharmaceutical product’s most important characteristic. Knowing how long a drug ...

Continuously driving pharmaceutical manufacturing efficiencies

Continuous manufacturing has long been accepted by a host of manufacturing industries from food and beverage to oil and ...

Realising the potential of single-use technology

Today’s growing pipeline of biological drugs require production environments that are agile and efficient, writes David ...

Particle Sciences strengthens nanomilling offering

New API screening programme is available from the CDMO

CPhI Worldwide returns to Italy

The large pharma event will be hosted at the Fiera Milano in 2020, with over 47,000 professionals expected to be in ...